Pilot: Impact of High-Dose, Single Fraction Radiation on Immunogenicity of Sipuleucel-T in Metastatic Castration Recurrent Prostate Cancer Patients
Phase of Trial: Phase I
Latest Information Update: 22 Mar 2018
At a glance
- Drugs Sipuleucel-T (Primary)
- Indications Prostate cancer
- Focus Pharmacodynamics; Pharmacogenomic
- 19 Mar 2018 Planned primary completion date changed from 5 Mar 2018 to 5 May 2018.
- 26 Dec 2017 Planned primary completion date changed from 5 Dec 2017 to 5 Mar 2018.
- 10 Jun 2017 Biomarkers information updated